PATENT CLAIM ANALYSIS

Application Number: 16198121
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-06
Patent Classification: ["424", "756000"]

Abstract:
This document provides dietary supplement compositions. For example, dietary supplement compositions having an acetylcholinesterase inhibitor (e.g., huperzine A), a  Bacopa monnieri  extract, acetyl-L-carnitine or acetyl CoA, and a curcuminoid (e.g., curcumin) are provided.

Claim (Index 7):
A composition comprising:\n (a) between about 0.01 and about 0.40 mg of huperzine A, (b) between about 200 mg and about 3000 mg of acetyl-L-carnitine, (c) between about 50 mg to about 1000 mg of  Bacopa monnieri,  (d) between about 25 mg and about 400 mg of curcumin, (e) between about 100 IU and about 800 IU of Vitamin E, and (f) between about 0.1 mg and about 10 mg of folic acid.

Metadata:
- Claim Count in Document: 15.0
- Percentile: 98.0
- Lexical Diversity: 1.40625
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14986846', '13693563', '12027652', '12080189', '14453861']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6956340068706969
- 35 USC 102 Novelty (BERT): 0.5122783861474999
- Combined Prediction Score: 0.6772984447983772
- Mean Citation Score: 192.8859
- Max Citation Score: 324.4502
- Similarity Product: 315.6368598190665

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test